Increasing Use of Dupilumab and Decreasing Use of Patch Testing in Medicare Patients from 2017 to 2022: A Claims Database Study
Dermatitis
.
2024 Nov 13.
doi: 10.1089/derm.2024.0416.
Online ahead of print.
Authors
Kathyana P Santiago Mangual
1
2
,
Akash Rau
3
,
Jane M Grant-Kels
4
5
,
Arianne Shadi Kourosh
1
6
,
Jenny E Murase
7
8
Affiliations
1
Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
2
David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
3
Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA.
4
Dermatology Department, University of Connecticut, Farmington, Connecticut, USA.
5
Dermatology Department, University of Florida, Gainesville, Florida, USA.
6
Harvard Medical School, Boston, Massachusetts, USA.
7
Department of Dermatology, University of California, San Francisco, California, USA.
8
Department of Dermatology, Palo Alto Foundation Medical Group, Mountain View, California, USA.
PMID:
39535824
DOI:
10.1089/derm.2024.0416
No abstract available
Publication types
Letter